Anika Therapeutics Inc (ANIK)

R&D Expenses

$27.45M

TTM · Period ending: · USD

ANIK logo

ANIK R&D Expenses

Latest reported$27.45M
ANIK TTM R&D Expenses ($1.60M → $27.45M)
High-resolution chart · PNG

ANIK r&d expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Anika Therapeutics Inc R&D Expenses — Trailing twelve months (TTM) (USD)
Period endingR&D Expenses (USD)
3,308,214
3,294,116
3,259,984
4,137,136
4,820,965
4,813,738
4,200,000
3,400,000
2,700,000
2,200,000
2,000,000
1,900,000
2,000,000
2,100,000
1,900,000
2,000,000
1,900,000
1,900,000
2,000,000
1,700,000
1,600,000
1,400,000
1,300,000
1,400,000
1,400,000
1,500,000
1,600,000
1,200,000
800,000
400,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.